VERICI DX PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.75 GBX | 0.00% |
|
-3.12% | -20.51% |
| May. 31 | Verici Dx launches educational website for kidney transplant patients | AN |
| May. 31 | Verici Dx Announces Launch of Patient-Focused Educational Tool | CI |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 82.92 | 75.13 | 21.29 | 18.8 | 18.8 | - |
| Enterprise Value (EV) 1 | 70.05 | 66.86 | 21.29 | 16.61 | 20.39 | 20.11 |
| P/E ratio | - | - | -2.25 x | - | - | - |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | 20.8 x | 3.21 x | 1.85 x |
| EV / Revenue | - | - | - | 20.8 x | 3.48 x | 1.98 x |
| EV / EBITDA | -68.9 x | -11.6 x | - | -2.63 x | -5.36 x | 20.2 x |
| EV / FCF | -110 x | -12 x | - | -3.57 x | -3.37 x | -71.3 x |
| FCF Yield | -0.91% | -8.32% | - | -28% | -29.7% | -1.4% |
| Price to Book | 3.37 x | 7.83 x | - | 5.03 x | 3.95 x | 3.77 x |
| Nbr of stocks (in thousands) | 141,748 | 141,748 | 170,319 | 242,541 | 242,541 | - |
| Reference price 2 | 0.5850 | 0.5300 | 0.1250 | 0.0775 | 0.0775 | 0.0775 |
| Announcement Date | 4/14/21 | 5/19/22 | 6/5/23 | 5/30/24 | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | 0.7968 | 5.86 | 10.16 |
| EBITDA 1 | -1.017 | -5.765 | - | -6.322 | -3.804 | 0.993 |
| EBIT 1 | -3.182 | -6.715 | - | -6.974 | -4.71 | 0.036 |
| Operating Margin | - | - | - | -875.32% | -80.38% | 0.35% |
| Earnings before Tax (EBT) | - | - | - | - | - | - |
| Net income | - | - | -9.185 | - | - | - |
| Net margin | - | - | - | - | - | - |
| EPS | - | - | -0.0556 | - | - | - |
| Free Cash Flow 1 | -0.638 | -5.562 | - | -5.684 | -6.047 | -0.282 |
| FCF margin | - | - | - | -718.58% | -103.19% | -2.77% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/14/21 | 5/19/22 | 6/5/23 | 5/30/24 | - | - |
1GBP in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 1.52 | 1.59 | 1.31 |
| Net Cash position 1 | 12.9 | 8.27 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | -0.2583 x | -0.4188 x | 1.32 x |
| Free Cash Flow 1 | -0.64 | -5.56 | - | -5.68 | -6.05 | -0.28 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets | - | - | - | - | - | - |
| Book Value Per Share 2 | 0.1700 | 0.0700 | - | 0.0200 | 0.0200 | 0.0200 |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - |
| Announcement Date | 4/14/21 | 5/19/22 | 6/5/23 | 5/30/24 | - | - |
1GBP in Million2GBP
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0775
GBP
Average target price
0.2
GBP
Spread / Average Target
+158.06%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -20.51% | 24.04M | |
| -4.52% | 12.39B | |
| -3.76% | 8.43B | |
| +6.71% | 5.77B | |
| +32.77% | 5.76B | |
| -10.21% | 4.1B | |
| +10.72% | 2.66B | |
| -61.42% | 2.66B | |
| -8.27% | 2.39B | |
| +17.66% | 2.02B |
- Stock Market
- Equities
- VRCI Stock
- Financials Verici Dx plc
